Midterm self-evaluation - published 17/2-2014 (click to download pdf document)
K.G. Jebsen Centre for Breast Cancer Research
Vision: Towards personalized therapy for breast cancer; integrated molecular and epidemiological studies of breast cancer to reduce risk, improve prognosis, and tailor the treatment.
Molecular group: Anne-Lise Børresen-Dale, director, OUS, UiO; Vessela N. Kristensen, deputy director, UiO, Ahus, OUS
Clinical group: Ellen Schlichting, Rolf Kåresen (Surgery), OUS, Torill Sauer, Elin Borgen, Hege G Russnes (Pathology), OUS, Erik Wist, Olav Engebråten, Bjørn Naume (Oncology), OUS
Micrometastasis group: Bjørn Naume, Øystein Fodstad , OUS
Model system group: Gunnhild M. Mælandsmo, Ø. Fodstad, OUS
Metabolic profiling group: T. Bathen, I. Gribbestad (passed away April 2013), NTNU
Bioinformatics/Biostatistics group: Ole Christian Lingjærde, UiO
Available positions - About the centre - Om senteret (på norsk)
The overall aim of the research Center is to open up for stronger collaboration between its clinical and basic scientists, and to motivate exchange of ideas on how to best utilize the huge collection of patient materials and data generated for the benefit of the patients. By such synergism we have been able to explore genes/pathways/networks involved in basic processes like cell cycle, DNA repair, apoptosis, and immune response and their impact on breast cancer (BC) development, progression and response to therapy. By performing longitudinal studies of samples at different stages of the disease and characterize such patient materials in full molecular details, we are moving towards a more individual treatment protocols.
Oslo Breast Cancer Research Consortium (OSBREAC).
The K.G. Jebsen Center for Breast Cancer Research is based on the long term activity in the Oslo Breast Cancer Research Consortium (OSBREAC).
The OSBREAC consists of the following key members. See a complete list.
Chair: Kristine Kleivi Sahlberg PhD, Department of Research, Vestre Viken Hospital, Drammen, Norway
Molecular group: Anne-Lise Børresen-Dale PhD, MD (h.c.), OUH, OUMF; Vessela N. Kristensen PhD, Akershus University Hospital (AUH), OUMF
Model-systems and Functional group: Gunhild M Mælandsmo PhD, OUH, OUMF; Øystein Fodstad PhD, MD, OUH, OUMF; Kristine Kleivi Sahlberg PhD, Vestre Viken Hospital, OUH
Micrometastases group: Bjørn Naume PhD, MD, OUH, OUMF; Øystein Fodstad PhD, MD, OUH, OUMF, Elin Borgen PhD, MD, OUH, OUMF
Clinical group: Ida Bukholm PhD, MD, AUH, OUMF; Britt Fritzmann MD, Østfold Hospital; Rolf Kåresen PhD, MD, OUH, OUMF; Ellen Schlichting PhD, MD, OUH, OUMF; Helle Skjerven MD, Vestre Viken Hospital (surgery); Olav Engebråten PhD, MD, OUH, OUMF; Bjørn Naume PhD, MD, OUH, OUMF; Erik Wist PhD, MD, OUH, OUMF (oncology)
Pathology group: Elin Borgen PhD, MD, OUH, OUMF; Hege G Russnes PhD, MD, OUH, OUMF; Torill Sauer PhD, MD, AUH; Jahn Nesland PhD, MD, OUH, OUMF
Metabolic profiling and Imaging group: Tone F. Bathen PhD, Norwegian University of Technology and Science (NTNU), PhD, Ingrid S. Gribbestad PhD, NTNU (passed away April 2013)
Bioinformatics and Biostatistics group: Ole Christian Lingjærde PhD, Oslo University (UiO)
Dr. Bastian Fromm – Postdoc in Flatmark group
Sep 26, 2016
Histone marks regulate maternal-to-zygotic transition
Sep 15, 2016